Protein name:
AFG3-like protein 2 ;
Alternative:
Paraplegin-like protein ;
Organism:
Human (Homo sapiens).
General Annotation
Function:
ATP-dependent protease which is essential for axonal development.
Subcellular Location:
Mitochondrion membrane
Multi-pass membrane protein
Protein Attributes:
50:
MAHRCLRLWG | RGGCWPRGLQ | QLLVPGGVGP | GEQPCLRTLY | RFVTTQARAS |
100:
RNSLLTDIIA | AYQRFCSRPP | KGFEKYFPNG | KNGKKASEPK | EVMGEKKESK |
150:
PAATTRSSGG | GGGGGGKRGG | KKDDSHWWSR | FQKGDIPWDD | KDFRMFFLWT |
200:
ALFWGGVMFY | LLLKRSGREI | TWKDFVNNYL | SKGVVDRLEV | VNKRFVRVTF |
250:
TPGKTPVDGQ | YVWFNIGSVD | TFERNLETLQ | QELGIEGENR | VPVVYIAESD |
300:
GSFLLSMLPT | VLIIAFLLYT | IRRGPAGIGR | TGRGMGGLFS | VGETTAKVLK |
350:
DEIDVKFKDV | AGCEEAKLEI | MEFVNFLKNP | KQYQDLGAKI | PKGAILTGPP |
400:
GTGKTLLAKA | TAGEANVPFI | TVSGSEFLEM | FVGVGPARVR | DLFALARKNA |
450:
PCILFIDEID | AVGRKRGRGN | FGGQSEQENT | LNQLLVEMDG | FNTTTNVVIL |
500:
AGTNRPDILD | PALLRPGRFD | RQIFIGPPDI | KGRASIFKVH | LRPLKLDSTL |
550:
EKDKLARKLA | SLTPGFSGAD | VANVCNEAAL | IAARHLSDSI | NQKHFEQAIE |
600:
RVIGGLEKKT | QVLQPEEKKT | VAYHEAGHAV | AGWYLEHADP | LLKVSIIPRG |
650:
KGLGYAQYLP | KEQYLYTKEQ | LLDRMCMTLG | GRVSEEIFFG | RITTGAQDDL |
700:
RKVTQSAYAQ | IVQFGMNEKV | GQISFDLPRQ | GDMVLEKPYS | EATARLIDDE |
750:
VRILINDAYK | RTVALLTEKK | ADVEKVALLL | LEKEVLDKND | MVELLGPRPF |
797:
AEKSTYEEFV | EGTGSLDEDT | SLPEGLKDWN | KEREKEKEEP | PGEKVAN
Vaild Sequence:
Related Databases
Uniprot:
ELISA Kit
CLIA Kit
Polyclonal Antibody
Monoclonal Antibody
Protein
FOR
Bovine
Mouse
Human
ELISA Kit for Human AFG3-like protein 2
ELISA Kit for Human AFG3-like protein 2
ELISA Kit for Human AFG3-like protein 2
CLIA Kit for Human AFG3-like protein 2
CLIA Kit for Human AFG3-like protein 2
CLIA Kit for Human AFG3-like protein 2
Polyclonal Antibody for Human AFG3-like protein 2
Polyclonal Antibody for Human AFG3-like protein 2
Polyclonal Antibody for Human AFG3-like protein 2
Monoclonal Antibody for Human AFG3-like protein 2
Monoclonal Antibody for Human AFG3-like protein 2
Monoclonal Antibody for Human AFG3-like protein 2
Protein for Human AFG3-like protein 2
Protein for Human AFG3-like protein 2
Protein for Human AFG3-like protein 2
R&D Technical Data
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Precision
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Recovery
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Linearity
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
References
1.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA];SUBCELLULAR LOCATION
2.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]
tissue :
Eye .
3.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : INTERACTION WITH SPG7
4.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : SUBUNIT
5.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
6.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : STRUCTURE BY NMR OF 164-251
7.
"Early onset and slow progression of SCA28, a rare dominant ataxia in a large four-generation family with a novel AFG3L2 mutation."
Edener U.
,
Wollner J.
,
Hehr U.
,
Kohl Z.
,
Schilling S.
,
Kreuz F.
,
Bauer P.
,
Bernard V.
,
Gillessen-Kaesbach G.
,
Zuhlke C.
Eur. J. Hum. Genet.18:965-968(2010)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT SCA28 LYS-700
8.
"Missense mutations in the AFG3L2 proteolytic domain account for approximately 1.5% of European autosomal dominant cerebellar ataxias."
Cagnoli C.
,
Stevanin G.
,
Brussino A.
,
Barberis M.
,
Mancini C.
,
Margolis R.L.
,
Holmes S.E.
,
Nobili M.
,
Forlani S.
,
Padovan S.
,
Pappi P.
,
Zaros C.
,
Leber I.
,
Ribai P.
,
Pugliese L.
,
Assalto C.
,
Brice A.
,
Migone N.
,
Durr A.
,
Brusco A.
more...
Hum. Mutat.31:1117-1124(2010)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS SCA28 ILE-654; VAL-666; ARG-666; THR-666; ARG-671 AND GLU-671
9.
"Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28."
Di Bella D.
,
Lazzaro F.
,
Brusco A.
,
Plumari M.
,
Battaglia G.
,
Pastore A.
,
Finardi A.
,
Cagnoli C.
,
Tempia F.
,
Frontali M.
,
Veneziano L.
,
Sacco T.
,
Boda E.
,
Brussino A.
,
Bonn F.
,
Castellotti B.
,
Baratta S.
,
Mariotti C.
,
Gellera C.
,
Fracasso V.
,
Magri S.
,
Langer T.
,
Plevani P.
,
Di Donato S.
,
Muzi-Falconi M.
,
Taroni F.
more...
Nat. Genet.42:313-321(2010)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS SCA28 THR-432; LYS-691; GLU-694 AND GLN-702;TISSUE SPECIFICITY
10.
"Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases."
Pierson T.M.
,
Adams D.
,
Bonn F.
,
Martinelli P.
,
Cherukuri P.F.
,
Teer J.K.
,
Hansen N.F.
,
Cruz P.
,
Mullikin J.C.
,
Blakesley R.W.
,
Golas G.
,
Kwan J.
,
Sandler A.
,
Fuentes Fajardo K.
,
Markello T.
,
Tifft C.
,
Blackstone C.
,
Rugarli E.I.
,
Langer T.
,
Gahl W.A.
,
Toro C.
more...
PLoS Genet.7:E1002325-E1002325(2011)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT SPAX5 CYS-616;CHARACTERIZATION OF VARIANT SPAX5 CYS-616